{"id":"NCT02066402","sponsor":"Bayer","briefTitle":"Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)","officialTitle":"A Phase 3 Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate and Intravenous to Oral 10-Day Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-03-04","primaryCompletion":"2016-03-06","completion":"2016-04-18","firstPosted":"2014-02-19","resultsPosted":"2017-06-07","lastUpdate":"2017-06-07"},"enrollment":598,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Bacterial Infections"],"interventions":[{"type":"DRUG","name":"Tedizolid (BAY119-2631)","otherNames":[]},{"type":"DRUG","name":"Placebo Tedizolid (BAY119-2631)","otherNames":[]},{"type":"DRUG","name":"Linezolid","otherNames":[]},{"type":"DRUG","name":"Placebo Linezolid","otherNames":[]}],"arms":[{"label":"Tedizolid Phosphate (Sivextro, BAY119-2631)","type":"EXPERIMENTAL"},{"label":"Linezolid","type":"ACTIVE_COMPARATOR"}],"summary":"This study is aimed to evaluate the efficacy and safety between Tedizolid 200mg daily (intra venous) I.V. to oral for 6-day treatment compared with that of Linezolid 600mg twice daily I.V. to oral for 10-day treatment Acute Bacterial Skin and skin structure infection (ABSSSI).This is a double-blind, randomized, active control, 7-10days treatment for all subjects.","primaryOutcome":{"measure":"Percentage of Participants With Early Clinical Response at 48-72 Hours After the First Infusion of Study Drug in the ITT Analysis Set.","timeFrame":"Baseline and 48-72 hours visit","effectByArm":[{"arm":"Tedizolid Phosphate (Sivextro, BAY119-2631)","deltaMin":75.3,"sd":null},{"arm":"Linezolid","deltaMin":79.9,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.2027"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":9},"locations":{"siteCount":55,"countries":["United States","China","Philippines","Taiwan"]},"refs":{"pmids":["30988146"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":292},"commonTop":["Nausea","Cellulitis","Diarrhoea","Pyrexia","Skin bacterial infection"]}}